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To the Editor:
We thank the authors of the editorial comment1 on our
review article2 for drawing attention to a paper by Privoulos et al3
regarding interpretation of the higher water content and long T1 of
the locus coeruleus (LC). We also appreciated their in-depth discussion of whether neuromelanin (NM) is being directly imaged or not.
A previous comment by Watanabe4 on Privoulos et al’s paper3
elegantly summarized exactly what we believe is seen with the low
ﬂip angle (FA) data, that is, high water content of gray matter tissues
with long T1. The work by Privoulos et al3 shows little magnetization transfer (MT) effect and their analysis suggests a small macromolecular fraction in the LC. Along these lines, this commentary1
refers to several 2019 publications5,6 and notes speciﬁcally that:
“These indicate a decreased transfer of magnetization from the
bound pool to the free water pool as well as from the free water pool
to the bound pool.” Indeed, as a result, the MT contrast (MTC)
data look very much like spin density-weighted images in the sense
that cerebrospinal ﬂuid (CSF) has high signal (no macromolecules
and, hence, no suppression of the signal) while the contrast between
gray matter and white matter is improved because the white matter
is suppressed more than the gray matter. The commentary also discusses matters related to the presence of both intracellular and extracellular water. The authors close their ﬁrst editorial comment paper
with a suggestion of what might happen with aging (in which
increasing T1 of the LC would suggest further reduction of the
bound pool). The authors note that, under these conditions, even if
there is an unchanged MTC signal intensity: “Accordingly, extracellular water fraction must increase to compensate for the reduced
macromolecular fraction (as long as the volume of the LC is not different).” Clearly, these types of changes with aging or physiological
changes associated with Parkinson’s disease are critical to investigate.
Now let us brieﬂy discuss the limit of low ﬂip angle spoiled
gradient echo imaging. We note that, as long as the FA is less than
the Ernst angle of white matter (ideally, much less), the images will
become more and more spin density-weighted (and with negligible
contributions from T1). To obtain a true proton density-weighted
image actually requires that the FA is much less than the lowest
Ernst angle for all tissues—this is on the order of 6 with a repetition time of 25 msec, since the T1 of CSF is on the order of
4500 msec. Of course, in very low FA images, CSF is indeed
brighter than the LC. Our ﬁrst estimates of the water content and
T1 of the LC yield roughly 80% and 1300 msec (in reasonable
agreement with Privoulos et al3 of roughly 1400 msec). These values
are, in fact, similar to most gray matter without high iron content. If
a 3D MTC pulse with low FA is used, then the white matter will be
further suppressed more than the LC while the CSF will be

unaffected making this appear “super spin density weighted” so to
speak. Knowing the tissue properties of the LC makes it possible to
optimize the contrast with or without an MT pulse.7
However, understanding the actual relationship between these
signals and the presence of NM is another story altogether. This was
the effort made by Watanabe and Privoulos in their elegant
papers.3,4 The second piece of information that appears to give some
consistency to this interpretation from an MRI perspective is that
the loss of NM in Parkinson’s disease patients corresponds also to an
increase in iron content and, hence, a loss of the N1 sign.8 Generally, water content drives T1 but other factors (such as the presence
of iron or exchange processes with macromolecules) can reduce T1.
However, this does not appear to be the case for the LC. The main
point in our review was that the water content seen with low FA
imaging correlates with the MT-NM results and with the loss in
MT-NM contrast seen in Parkinson’s disease patients.
Given the above-mentioned detailed ﬁndings about the LC
regarding its response to an MT pulse, the commentary1 suggests
that it is not the NM per se that has increased water content.
Indeed, we probably should have referred to this as being from the
increased water content in the NM-containing tissue (whether it is
from the larger noradrenergic neurons or not is not the question
here). There could indeed be secondary or association effects that
the presence of NM correlates with high water content in the tissues;
however, upon degradation, this water-driven contrast disappears.
The potential role of intracellular and extracellular water effects in
explaining this behavior is amply discussed by Watanabe.4,5 Further,
given the sensitivity to water content, the authors close their comment on our review paper2 with “reduced LC/SN signal intensity
suggests reduced amount of intracellular water, e.g., as a result of
NA/DA neuron loss. Thus, LC/SN signal intensity is, although not
attributable to NM, likely to correlate with NM (as well as with
intracellular water) because NM as an effective metal chelator provides neuronal protection and decreases with NA/DA neuron loss.”
We are in agreement that the LC contrast seen in MR is associated
with tissue containing NM but not directly from the NM itself.
Keren’s work9 is a key paper in the ﬁeld that set the stage for
the community’s choice of nomenclature, that is designating the LC
contrast seen with MR as “NM imaging.” Their excellent paper
shows a colocation of NM cells in the LC that corresponds to norepinephrine neurons with the MTC NM-MRI data. They remark:
“Thus, neuromelanin appears to serve as a natural contrast agent for
nucleus LC that can be used to localize nucleus LC and may have
the potential to characterize neurodegenerative disease.” In Keren’s
ﬁgure 5, they show a clear correlation between the density of
staining of the tyrosine hydroxylase and LC neurons with the MR
enhancement seen in the LC. So, it is not unreasonable that they
have assumed the source of contrast is NM. But as mentioned
above, it is more of an association rather than a direct measure of
NM, as suggested by Watanabe. Keren’s histological staining also
contained cadaver brain samples from subjects with Alzheimer’s
disease and Lewy body disease. Evidently, they found consistent
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LETTER TO THE EDITOR

correlations in all cases. These results suggest again that it is the high
water content producing this contrast. Taken together, the available
information points to the same idea, that the MR LC imaging
(whichever approach is used) is associated with the noradrenergic
neurons and the presence of NM. Keren concludes: “We have
demonstrated that neuromelanin is a primary contributor to
LC-MRI contrast that is observed in neuroimaging studies of human
subjects.” and “These results indicate that neuromelanin serves as a
natural contrast agent for identifying the location of nucleus LC.”
So, you cannot blame the neuroimaging community for designating
these ﬁndings as NM imaging.
Similarly, Kitao et al10 studied NM MRI in the SN and compared these ﬁndings to histology. However, their conclusion is stated
more as an association: “Based on the direct correlation between postmortem NmMRI and neuropathological ﬁndings, signal intensity in
the SNc is closely related to the quantity of neuromelanin-containing
neurons but is not inﬂuenced by iron deposition.” Therefore, we
agree that this enhanced contrast from water is indeed associated with
the NM-containing neurons and not necessarily caused by the direct
presence of the NM but, rather, its association with these neurons.
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